|
|
|
| Clinical effect of Donepezil combined with Olanzapine in the treatment of senile dementia patients with mental and behavioral symptoms |
| LIANG Dong-xu |
| Department of Psychiatry,Kangning Hospital of Chaoyang City,Liaoning Province,Chaoyang 122000,China |
|
|
|
|
Abstract Objective To investigate the clinical effect of Donepezil combined with Olanzapine in the treatment of senile patients suffering from dementia with mental and behavioral symptoms.Methods A total of 50 senile dementia patients with mental and behavioral symptoms who were admitted to our hospital from May to September in 2019 were randomly selected as the research subjects.According to different treatments,they were divided into the control group and the study group,with 25 cases in each group.In the control group,Donepezil was used,and in the study group,Donepezil + Olanzapine was adopted.The BEHAVE-AD scores before and after treatment,the occurrence of adverse reactions and the Wisconsin card sorting test (WCST) cognitive function score of the two groups were observed and compared.Results There was no statistically significant difference in the BEHAVE-AD scores between the two groups before treatment (P＞0.05).The BEHAVE-AD scores of the two groups after 8 weeks of treatment were lower than those of 4 and 6 weeks after treatment,and the BEHAVE-AD scores of the two groups after 6 weeks of treatment were lower than those of 4 weeks after treatment,with statistical significance (P＜0.05).The BEHAVE-AD scores of the study group at 4,6,8 weeks after treatments were all lower than those of the control group,and the differences were statistically significant (P＜0.05).The total incidence of adverse reactions in the study group after treatment was lower than in the control group,and the difference was statistically significant (P＜0.05).There were no statistically significant differences in the WCST total test trials,random error number,perseverative error number,correct response trials and categories number between the two groups before treatment (P＞0.05).After treatment,the WCST total test trials,random error number,and perseverative error number in the study group were lower than those of the control group,the correct response trials and categories number of the study group after treatment were higher than those of the control group,and the differences were statistically significant (P＜0.05).Conclusion The combined treatment of Donepezil and Olanzapine can improve the senile dementia patients with mental and behavioral symptoms associated and enhance cognitive ability in good safety.
|
|
|
|
|
|
| [1] |
孙锦红.多奈哌齐合并奥氮平治疗以精神行为症状首发阿尔茨海默病患者的临床效果评价[J].中国医药指南，2018，16（16）：324-424.
|
| [2] |
徐丹.奥氮平联合多奈哌齐治疗对老年阿尔茨海默病患者认知功能的改善作用[J].中外医疗，2019，38（24）：106-109.
|
| [3] |
张子盈.丙戊酸镁缓释片与盐酸多奈哌齐胶囊治疗老年痴呆精神行为障碍的效果观察[J].中国实用医刊，2018，45（23）：121-123.
|
| [4] |
戴云飞，肖泽萍.中国精神障碍分类与诊断标准第3版与国际疾病分类第10版的比较[J].临床精神医学杂志，2013，23（6）：426-427.
|
| [5] |
薛晓静，何饶丽，李伟兴，等.非典型抗精神病药治疗痴呆精神行为症状安全性的系统评价[J].中华医学杂志，2018，98（25）：2030-2036.
|
| [6] |
吕云峰.盐酸多奈哌齐联合用药方案延缓老年痴呆患者病情的临床分析[J].中国实用医药，2018，13（2）：107-109.
|
| [7] |
马明辉.多奈哌齐与尼莫地平联合治疗老年期血管性痴呆的临床观察[J].中国老年保健医学，2018，16（2）：13-15.
|
| [8] |
艾艳萍，丁涛.多奈哌齐联合依达拉奉对脑梗死后血管性痴呆的疗效研究[J].西南国防医药，2018，28（6）：21-22.
|
| [9] |
丁燕莉，徐韩，陈剑华.CYP1A2 酶基因多态性与奥氮平治疗老年性痴呆精神行为症状疗效的关联性[J].神经疾病与精神卫生，2018，18（3）：15-17.
|
| [10] |
黄桥生，徐止浩.补肾健脑方联合奥氮平治疗精神行为障碍老年痴呆疗效观察[J].现代中西医结合杂志，2019，28（24）：2701-2703.
|
| [11] |
叶层德.多奈哌齐片联合奥拉西坦注射液治疗血管性痴呆患者的临床效果[J].医疗装备，2018，31（14）：34-37.
|
| [12] |
姚爱娜，杨发明.盐酸多奈哌齐联合康复训练治疗脑卒中后血管性痴呆临床研究[J].实用医技杂志，2019，26（5）：596-598.
|
| [13] |
程度，晁志文，何远宏，等.多奈哌齐联合喹硫平对阿尔茨海默病患者的认知功能和精神症状的疗效[J].国际精神病学杂志，2019，46（3）：31-33.
|
| [14] |
张子盈.丙戊酸镁缓释片与盐酸多奈哌齐胶囊治疗老年痴呆精神行为障碍的效果观察[J].中国实用医刊，2018，45（23）：121-123.
|
| [15] |
李刚，马云霞，范其江，等.盐酸多奈哌齐治疗血管性痴呆的效果及对患者认知功能、血清胰岛素样生长因子-1水平的影响[J].中国实用医刊，2019，46（12）：114-117.
|
|
|
|
